Raas inhibitors are associated with a better chance of surviving of inpatients with covid-19 without a diagnosis of diabetes mellitus, compared with similar patients who did not require antihypertensive therapy or were treated with other antihypertensive

HIGHLIGHTS

• who: Mykola Khalangot et al. from the University of Bristol, United Kingdom have published the research: RAAS inhibitors are associated with a better chance of surviving of inpatients with Covid-19 without a diagnosis of diabetes mellitus, compared with similar patients who did not require antihypertensive therapy or were treated with other antihypertensive, in the Journal: (JOURNAL)

SUMMARY

The renin-angiotensin-aldosterone system (RAAS) signaling and angiotensin-converting enzyme 2 (ACE2) have been implicated in the pathogenesis of COVID-19 because ACE2 - an enzyme that physiologically counteracts RAAS activation, is a functional receptor . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.